UPDATE: Express Scripts' stock rocked by tweets from short seller Andrew Left
Fitch Affirms Express Scripts at 'BBB'; Outlook Stable
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
Investors can pick up shares of this pharmacy benefit manager, which enjoys enormous supplier-pricing and scale advantages, at a significant discount.
The wide-moat pharmacy benefit manager is still undervalued.
Misunderstanding on private health insurance exchanges could mean opportunity for investors.
The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.
If Americans sweep Democrats into office, these healthcare proposals could get a shot in the arm. Here’s how they would have an impact on earnings.
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.